Tuesday, December 13, 2011

BASF, GlaxoSmithKline, Merck and Novartis Among Companies to Schedule Partnering Sessions at CED Life Science Conference 2012

Early registration encouraged to secure limited opportunities

 CED, the Southeast’s largest entrepreneurial support organization, today opened registration for partnering sessions at the CED Life Science Conference 2012, scheduled for February 15-16 at the Raleigh Convention Center.  The partnering sessions will be open to all conference participants, and priority consideration will be given to those who register early.

Corporate partners confirmed for the conference include Abbott, BASF, Bayer Crop Science, GlaxoSmithKline, LabCorp, Merck, Novartis, and United Therapeutics. In addition to requesting opportunities to schedule 30-minute private networking meetings with these companies, participants also will have the opportunity to request meetings with investors, emerging life science companies and university technology transfer officers.

“We participated in two partnering sessions in 2011 that were quite constructive and vital for moving our company forward to potential licensing discussions,” said Steven E. Peterson, CEO of Trana Discovery, Inc. Peterson plans to participate in the partnering sessions in 2012, as well.

“Anytime we can bring people together to partner in forums such as this, we open doors to significant collaborations and opportunities to commercialize important new technologies,” said Norris Tolson, president and CEO of the NorthCarolina Biotechnology Center.

The CED Life Science Conference 2012 is presented in partnership with the North Carolina Biotechnology Center and North Carolina Biosciences Organization. Early registration and a full conference agenda can be found online at: http://www.cednc.org/lifescience

For the full press release from CED, please refer to the CED Press Room.